Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.40 |
| ▸ | ESR1 | P03372 | 3/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.35 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.35 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3298753 | 0.89 | KDM4E (0.44) | KDM4EESR1MAPTMAPK1NPSR1 | |
| SCHEMBL3296126 | 0.86 | ALDH1A1 (0.40) | KDM4EESR1MAPTMAPK1NPSR1 | |
| SCHEMBL3295354 | 0.81 | LTA4H (0.43) | MAPTGAACYP1A2CYP2C9CYP2C19 | |
| SCHEMBL10223630 | 0.80 | KDM4E (0.50) | KDM4EESR1MAPTMAPK1NPSR1 | |
| SCHEMBL3298043 | 0.80 | L3MBTL1 (0.41) | KDM4EMAPTMAPK1NPSR1SMN1; SMN2 | |
| SCHEMBL3300336 | 0.78 | GLA (0.39) | KDM4EMAPTMAPK1SMN1; SMN2CYP1A2 | |
| SCHEMBL27548244 | 0.78 | KDM4E (0.47) | KDM4EESR1MAPTMAPK1NPSR1 | |
| SCHEMBL3298741 | 0.77 | CA1 (0.39) | MAPTNPSR1SMN1; SMN2ALDH1A1 | |
| SCHEMBL3299743 | 0.77 | CYP1A2 (0.40) | ESR1SMN1; SMN2CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL15187973 | 0.76 | KDM4E (0.66) | KDM4EESR1MAPTMAPK1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7741393-B2 | Organic silicon-based compound and method of producing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-06-22 | — | — | US | disclosed |
| US-20070203275-A1 | Organic Silicon-Based Compound And Method Of Producing The Same | SUMITOMO CHEMICAL COMPANY, LIMITED | 2007-08-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070203275-A1 | Organic Silicon-Based Compound And Method Of Producing The Same | ARSA, OR10J3, HDAC10 | KDM4E 1578/4885ESR1 2821/4885MAPT 2685/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.